We are a financial services provider for several types of professional clients, each with distinct needs.
BUSINESS ACCOUNT
Access reports individually or via Subscription
Receive monthly invoices with payment via CSA or hard dollars
Analyst access
Free Trial Subscriptions
Team account with shared subscriptions
Advanced analytics to track research consumption and performance
Amoéba has conducted, in partnership with Koppert, an extensive programme of field trials in Brazil to assess the potential of its AXPERA biofungicide technology on several key crops, such as soya and orange trees, of which Brazil is the world's leading producer. We maintain our Buy and € 1.4 Target Price.
Over the past months, the strength of the AI cycle has been remarkably strong, reflected in significant increases in hyperscalers' CapEx, which have supported higher revenues for semiconductor manufacturers and driven incremental investments. Memory, in particular, benefitted from the strong increase in demand. We expect a strong year for ASML in 2026, but remain cautious on 2027 and beyond, mainly due to revenue and CapEx cyclicality at memory players and market-share expectations for ASML post...
Rising interest rates are becoming a hot topic, triggered by a significant uptick in US 10-year treasury yields through February and March. In this note we revisit this topic from several angles. We dig into the empirical side of what we can reasonably expect from the market as a whole when interest rates start to rise. Secondly we review our coverage, putting forward a number of impacted sectors and stocks.